当前位置： SCI文献检索 > ONCOGENE期刊下所有文献 > Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure.

Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure.

Abstract：

:A hallmark of cancer is the deregulation of cell-cycle machinery, ultimately facilitating aberrant proliferation that fuels tumorigenesis and disease progression. Particularly, in breast cancers, cyclin D1 has a crucial role in the development of disease. Recently, a highly specific inhibitor of CDK4/6 activity (PD-0332991) has been developed that may have efficacy in the treatment of breast cancer. To interrogate the utility of PD-0332991 in treating breast cancers, therapeutic response was evaluated on a panel of breast cancer cell lines. These analyses showed that the chronic loss of Rb is specifically associated with evolution to a CDK4/6-independent state and, ultimately, resistance to PD-0332991. However, to interrogate the functional consequence of Rb directly, knockdown experiments were performed in models that represent immortalized mammary epithelia and multiple subtypes of breast cancer. These studies showed a highly specific role for Rb in mediating the response to CDK4/6 inhibition that was dependent on transcriptional repression manifest through E2F, and the ability to attenuate CDK2 activity. Acquired resistance to PD-03322991 was specifically associated with attenuation of CDK2 inhibitors, indicating that redundancy in CDK functions represents a determinant of therapeutic failure. Despite these caveats, in specific models, PD-0332991 was a particularly effective therapy, which induced Rb-dependent cytostasis. Combined, these findings indicate the critical importance of fully understanding cell-cycle regulatory pathways in directing the utilization of CDK inhibitors in the clinic.

journal_name

Oncogene

journal_title

Oncogene

authors

Dean JL,Thangavel C,McClendon AK,Reed CA,Knudsen ES

doi

10.1038/onc.2010.154

subject

Has Abstract

pub_date

2010-07-15 00:00:00

pages

4018-32

issue

28

eissn

0950-9232

issn

1476-5594

pii

onc2010154

journal_volume

29

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site-directed mutagenesis.

    abstract：:The gene for von Recklinghausen neurofibromatosis type 1 (NF1) was recently identified by positional cloning and found to encode a protein with sequence similarity to a family of eucaryotic GTPase-activating proteins (GAPs). Expression of the NF1-GAP-related domain (NF1GRD) has been shown to complement yeast strains d...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Gutmann DH,Boguski M,Marchuk D,Wigler M,Collins FS,Ballester R

    更新日期：1993-03-01 00:00:00

  • Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma.

    abstract：:WEE1 kinase has been described as a major gate keeper at the G2 cell cycle checkpoint and to be involved in tumour progression in different malignant tumours. Here we analysed the expression levels of WEE1 in a series of melanoma patient samples and melanoma cell lines using immunoblotting, quantitative real-time PCR ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2012.324

    authors： Bhattacharya A,Schmitz U,Wolkenhauer O,Schönherr M,Raatz Y,Kunz M

    更新日期：2013-06-27 00:00:00

  • BIN1 reverses PD-L1-mediated immune escape by inactivating the c-MYC and EGFR/MAPK signaling pathways in non-small cell lung cancer.

    abstract：:Non-small cell lung cancer (NSCLC) is one of the most common and malignant carcinoma worldwide, and the incidence and mortality are increasing rapidly. Immunotherapy targeting programmed death 1/programmed death ligand 1 (PD-L1) signaling has shown prominent clinical effects in treating NSCLC; however, a poor understa...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2017.217

    authors： Wang J,Jia Y,Zhao S,Zhang X,Wang X,Han X,Wang Y,Ma M,Shi J,Liu L

    更新日期：2017-11-09 00:00:00

  • Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer.

    abstract：:Inherited mutations in the BRCA1 gene confer increased susceptibility to breast and ovarian cancer. Its role in sporadic carcinogenesis is not well defined. Somatic mutations in breast cancers have not been reported and to date there are only three reports of somatic mutations in sporadic ovarian cancers. To investiga...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1202847

    authors： Khoo US,Ozcelik H,Cheung AN,Chow LW,Ngan HY,Done SJ,Liang AC,Chan VW,Au GK,Ng WF,Poon CS,Leung YF,Loong F,Ip P,Chan GS,Andrulis IL,Lu J,Ho FC

    更新日期：1999-08-12 00:00:00

  • Leukaemia lineage specification caused by cell-specific Mll-Enl translocations.

    abstract：:Chromosomal translocations involving the Mixed-Lineage Leukaemia (MLL) gene underlie many human leukaemias and MLL rearrangements are found in both acute myelogenous and acute lymphoblastic leukaemias. To assess the functionally relevant haematopoietic cell contexts for MLL fusions to be tumorigenic, we have generated...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1210818

    authors： Cano F,Drynan LF,Pannell R,Rabbitts TH

    更新日期：2008-03-20 00:00:00

  • Core transcriptional regulatory circuitries in cancer.

    abstract：:Transcription factors (TFs) coordinate the on-and-off states of gene expression typically in a combinatorial fashion. Studies from embryonic stem cells and other cell types have revealed that a clique of self-regulated core TFs control cell identity and cell state. These core TFs form interconnected feed-forward trans...

    journal_title：Oncogene

    pub_type： 杂志文章,评审

    doi：10.1038/s41388-020-01459-w

    authors： Chen Y,Xu L,Lin RY,Müschen M,Koeffler HP

    更新日期：2020-10-01 00:00:00

  • Human p53 binds DNA as a protein homodimer but monomeric variants retain full transcription transactivation activity.

    abstract：:Wild-type human p53 protein is able to self-associate and consists predominantly of homotetramers in solution. In earlier work we identified the protein sequence motifs involved in p53 quaternary structure and showed that while monomeric p53 protein retains tumour suppressor function, monomeric tumour mutant p53 lacks...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Tarunina M,Jenkins JR

    更新日期：1993-11-01 00:00:00

  • SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells.

    abstract：:SPARC, also termed osteonectin, BM-40 and 43K protein, is an acidic, cysteine-rich component of the extracellular matrix that has been shown to be directly regulated by progesterone and dexamethasone and indirectly by cytokines. By RNA fingerprinting technique, we cloned a SPARC homolog from the normal human ovarian s...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Mok SC,Chan WY,Wong KK,Muto MG,Berkowitz RS

    更新日期：1996-05-02 00:00:00

  • Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels.

    abstract：:Among surface molecules expressed on endothelial cells, endoglin (CD105) is emerging as a prime vascular target for antiangiogenetic cancer therapy. CD105 is a cell membrane glycoprotein mainly expressed on endothelial cells and overexpressed on tumor-associated vascular endothelium, which functions as an accessory co...

    journal_title：Oncogene

    pub_type： 杂志文章,评审

    doi：10.1038/sj.onc.1206813

    authors： Fonsatti E,Altomonte M,Nicotra MR,Natali PG,Maio M

    更新日期：2003-09-29 00:00:00

  • BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.

    abstract：:BRCA1, a familial breast and ovarian cancer susceptibility gene encodes nuclear phosphoproteins that function as tumor suppressors in human breast cancer cells. Previously, we have shown that overexpression of a BRCA1 splice variant BRCA1a accelerates apoptosis in human breast cancer cells. In an attempt to determine ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1201252

    authors： Wang H,Shao N,Ding QM,Cui J,Reddy ES,Rao VN

    更新日期：1997-07-10 00:00:00

  • The retinoblastoma gene family in differentiation and development.

    abstract：:The retinoblastoma (Rb) tumor suppressor gene and its close relatives p107 and p130 are best known for their function in the control of cell cycle progression. In recent years, however, a new role for these proteins has been emerging as they have been linked with regulation of terminal differentiation of many tissues ...

    journal_title：Oncogene

    pub_type： 杂志文章,评审

    doi：10.1038/sj.onc.1203244

    authors： Lipinski MM,Jacks T

    更新日期：1999-12-20 00:00:00

  • Activation of N-ras and K-ras induced by interleukin-6 in a myeloma cell line: implications for disease progression and therapeutic response.

    abstract：:Ras is a major signaling molecule activated by interleukin-6. There have been no published reports, however, that specifically examine the kinetics and percentage of Ras activation in response to IL-6. Model cell lines were used to study activation of N- and K-ras induced by IL-6. All of the myeloma cell lines we test...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1205387

    authors： Rowley M,Van Ness B

    更新日期：2002-12-12 00:00:00

  • The MYCN protein of human neuroblastoma cells is phosphorylated by casein kinase II in the central region and at serine 367.

    abstract：:The MYCN gene has been implicated in certain neuronal tumours, such as neuroblastomas and retinoblastomas. These tumours express high levels of mRNA and protein of MYCN as a result of amplification. MYCN encodes a short-lived nuclear phosphoprotein whose function has not yet been elucidated. This study was undertaken ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Hamann U,Wenzel A,Frank R,Schwab M

    更新日期：1991-10-01 00:00:00

  • Low expression of pro-apoptotic Bcl-2 family proteins sets the apoptotic threshold in Waldenström macroglobulinemia.

    abstract：:Waldenström macroglobulinemia (WM) is a proliferative disorder of IgM-secreting, lymphoplasmacytoid cells that inhabit the lymph nodes and bone marrow. The disease carries a high prevalence of activating mutations in MyD88 (91%) and CXCR4 (28%). Because signaling through these pathways leads to Bcl-xL induction, we ex...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2015.103

    authors： Gaudette BT,Dwivedi B,Chitta KS,Poulain S,Powell D,Vertino P,Leleu X,Lonial S,Chanan-Khan AA,Kowalski J,Boise LH

    更新日期：2016-01-28 00:00:00

  • Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.

    abstract：:Mouse embryonal carcinoma (EC) cells of the P19 line can be induced to differentiate into neurons, astrocytes and fibroblasts by exposure to retinoic acid (RA), whereas treatment of the EC cells with dimethyl sulfoxide (DMSO) leads to differentiation into mesodermal tissues, including cardiac and skeletal muscle. In R...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： St-Arnaud R,Nepveu A,Marcu KB,McBurney MW

    更新日期：1988-11-01 00:00:00

  • Phosphorylation at serine 28 and acetylation at lysine 9 of histone H3 induced by trichostatin A.

    abstract：:Trichostatin A (TSA), a histone deacetylase inhibitor, strongly increases acetylation of the N-terminal tails of histone H3. Many studies have correlated the function of TSA with the hyperacetylation of histone. Although histone H3 is known to be phosphorylated, the effect of acetylation on phosphorylation is not know...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1206507

    authors： Zhong S,Goto H,Inagaki M,Dong Z

    更新日期：2003-08-14 00:00:00

  • Regional localization of the human c-rel locus using translocation chromosome analysis.

    abstract：:The human cellular homolog of v-rel, the transforming gene of reticuloendotheliosis virus, strain T, was previously localized to 2 cent-2p13 by a combination of somatic cell hybrid and in situ hybridization analyses. In this study, we use translocation chromosome analysis to refine c-rel's genetic assignment to 2p12-2...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Brownell E,Fell HP,Tucker PW,Geurts van Kessel AH,Hagemeijer A,Rice NR

    更新日期：1988-05-01 00:00:00

  • Human c-FES is a nuclear tyrosine kinase.

    abstract：:FES is a non-receptor protein tyrosine kinase expressed in hematopoietic progenitors and differentiated myeloid cells. It has recently been implicated in granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3) and erythropoietin signal transduction. To better understand the role played by FES i...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Yates KE,Lynch MR,Wong SG,Slamon DJ,Gasson JC

    更新日期：1995-03-16 00:00:00

  • Shc3 affects human high-grade astrocytomas survival.

    abstract：:A selective switch from expression of Shc1 gene to Shc3 occurs with maturation of neuronal precursors into postmitotic neurons. Previous studies showed that in the embryo, Shc1 is maximally expressed in dividing CNS stem cells while it is silenced in mature neurons, where it is replaced by Shc3. Under normal condition...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1208708

    authors： Magrassi L,Conti L,Lanterna A,Zuccato C,Marchionni M,Cassini P,Arienta C,Cattaneo E

    更新日期：2005-08-04 00:00:00

  • A 5'-CG-3'-rich region in the promoter of the transcriptionally frequently silenced RET protooncogene lacks methylated cytidine residues.

    abstract：:In a large proportion of familial and sporadic cases of Hirschsprung disease (HSCR) mutations in the RET (rearranged during transfection) protooncogene have been described. We have investigated the structure of the RET gene promoter and have analysed a region of approximately 1000 nucleotides in its promoter and 5'-up...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1202165

    authors： Munnes M,Patrone G,Schmitz B,Romeo G,Doerfler W

    更新日期：1998-11-19 00:00:00

  • Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.

    abstract：:Experimental studies performed prior to 1990 led to the widely held belief that matrix metalloproteinases (MMPs) produced by cancer cells are of critical importance in tumor invasion and metastasis. Based on this evidence, the pharmaceutical industry produced several well tolerated, orally active MMP inhibitors (MMPIs...

    journal_title：Oncogene

    pub_type： 杂志文章,评审

    doi：10.1038/sj.onc.1204097

    authors： Zucker S,Cao J,Chen WT

    更新日期：2000-12-27 00:00:00

  • c-fos and c-jun overexpression in malignant cells reduces their tumorigenic and metastatic potential, and affects their MHC class I gene expression.

    abstract：:Reduced co-expression of the c-fos and c-jun protooncogenes has been correlated with the down regulation of H-2K class I major histocompatibility antigens in high-metastatic cell lines from the Lewis lung carcinoma, B16 melanoma and the K1735 melanoma. Transfection of c-jun and c-fos genes into the high metastatic clo...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Yamit-Hezi A,Plaksin D,Eisenbach L

    更新日期：1994-04-01 00:00:00

  • VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop.

    abstract：:Vascular endothelial growth factor-A (VEGF-A) is highly subjected to alternative pre-mRNA splicing that generates several splice variants. The VEGFxxx and VEGFxxxb families encode splice variants of VEGF-A that differ only at the level of six amino acids in their C-terminal part. The expression level of VEGFxxx splice...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/s41388-018-0486-7

    authors： Boudria A,Abou Faycal C,Jia T,Gout S,Keramidas M,Didier C,Lemaître N,Manet S,Coll JL,Toffart AC,Moro-Sibilot D,Albiges-Rizo C,Josserand V,Faurobert E,Brambilla C,Brambilla E,Gazzeri S,Eymin B

    更新日期：2019-02-01 00:00:00

  • Hyperactivation of EGFR and downstream effector phospholipase D1 by oncogenic FAM83B.

    abstract：:Despite the progress made in targeted anticancer therapies in recent years, challenges remain. The identification of new potential targets will ensure that the arsenal of cancer therapies continues to expand. FAM83B was recently discovered in a forward genetic screen for novel oncogenes that drive human mammary epithe...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2013.293

    authors： Cipriano R,Bryson BL,Miskimen KL,Bartel CA,Hernandez-Sanchez W,Bruntz RC,Scott SA,Lindsley CW,Brown HA,Jackson MW

    更新日期：2014-06-19 00:00:00

  • A new fusion gene NUP98-IQCG identified in an acute T-lymphoid/myeloid leukemia with a t(3;11)(q29q13;p15)del(3)(q29) translocation.

    abstract：:NUP98 has been involved in multiple recurrent chromosome rearrangements in leukemia. We identified a novel fusion between NUP98 and IQ motif containing G (IQCG) gene from a de novo acute T-lymphoid/myeloid leukemia harboring t(3;11)(q29q13;p15)del(3)(q29). IQCG has two putative coiled-coil domains and one IQ domain. T...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1210999

    authors： Pan Q,Zhu YJ,Gu BW,Cai X,Bai XT,Yun HY,Zhu J,Chen B,Weng L,Chen Z,Xue YQ,Chen SJ

    更新日期：2008-05-29 00:00:00

  • Mutant p53 detected in a majority of Burkitt lymphoma cell lines by monoclonal antibody PAb240.

    abstract：:The status of the p53 gene in lymphoblastoid cell lines (LCLs) and Burkitt lymphoma cell lines (BLs) was investigated. Southern blot analysis demonstrated that no major deletions or rearrangements had occurred in the p53 gene in any of the cell lines. The p53 protein was examined by immunoprecipitation using two monoc...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Wiman KG,Magnusson KP,Ramqvist T,Klein G

    更新日期：1991-09-01 00:00:00

  • Upregulation of histamine receptor H1 promotes tumor progression and contributes to poor prognosis in hepatocellular carcinoma.

    abstract：:H1 histamine receptor (H1HR) belongs to the family of rhodopsin-like G-protein-coupled receptors. Recent studies have shown that H1HR expression is increased in several types of cancer. However, its functional roles in tumor progression remain largely unknown, especially in hepatocellular carcinoma (HCC). We found tha...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/s41388-019-1093-y

    authors： Zhao J,Hou Y,Yin C,Hu J,Gao T,Huang X,Zhang X,Xing J,An J,Wan S,Li J

    更新日期：2020-02-01 00:00:00

  • Human mammary epithelial cells exhibit a differential p53-mediated response following exposure to ionizing radiation or UV light.

    abstract：:The tumor suppressor protein, p53, plays a critical role as a transcriptional activator of downstream target genes involved in the cellular response to DNA damaging agents. We examined the cell cycle checkpoint response of human mammary epithelial cells (HMEC) and their isogenic fibroblast counterparts to ionizing (IR...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1202977

    authors： Meyer KM,Hess SM,Tlsty TD,Leadon SA

    更新日期：1999-10-14 00:00:00

  • Nuclear DLC1 exerts oncogenic function through association with FOXK1 for cooperative activation of MMP9 expression in melanoma.

    abstract：:A Rho GTPase-activating protein (RhoGAP), deleted in liver cancer 1 (DLC1), is known to function as a tumor suppressor in various cancer types; however, whether DLC1 is a tumor-suppressor gene or an oncogene in melanoma remains to be clarified. Here we revealed that high DLC1 expression was detected in most of the mel...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/s41388-020-1274-8

    authors： Yang X,Hu F,Liu JA,Yu S,Cheung MPL,Liu X,Ng IO,Guan XY,Wong KKW,Sharma R,Lung HL,Jiao Y,Lee LTO,Cheung M

    更新日期：2020-05-01 00:00:00

  • CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines.

    abstract：:Tumor suppressor gene CDKN2 (also called MTS1, CDK4I and p16INK4) is located in 9p21 and deleted homozygously in a high percentage of tumor cell lines. We have examined the sequence of CDKN2 in 154 tumor cell lines that are not homozygously deleted for CDKN2. Overall, 18% (27/154) of the cell lines carried mutations i...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Liu Q,Neuhausen S,McClure M,Frye C,Weaver-Feldhaus J,Gruis NA,Eddington K,Allalunis-Turner MJ,Skolnick MH,Fujimura FK

    更新日期：1995-03-16 00:00:00